Surgical Blade Industry Overview

The global surgical blade market size was estimated at USD 202.7 million in 2023 and is projected to grow at a CAGR of 5.30% from 2024 to 2030.

The increasing prevalence of chronic diseases, an aging population, rising number of surgical procedures, and advancements in surgical techniquesare major factors driving the market growth. According to the International Society of Aesthetic Plastic Surgery, 26.2 million surgical procedures were performed in U.S. in 2022. This includes both aesthetic and reconstructive surgeries, indicating a substantial volume of surgical activity in the region, propelling the market growth for surgical blades.

Gather more insights about the market drivers, restrains and growth of the Surgical Blade Market

The increasing prevalence of chronic diseases is a primary driver of the global market. Diseases such as cardiovascular conditions, cancer, and diabetes are rising at an alarming rate, significantly contributing to the surge in surgical procedures worldwide. For instance, cardiovascular diseases are the leading cause of death globally, accounting for nearly 18 million deaths annually, according to the World Health Organization (WHO).  This high incidence necessitates numerous surgical interventions, including coronary artery bypass grafting and angioplasty, which require precise and reliable surgical blades. Similarly, cancer cases are increasing, According to the International Agency for Research on Cancer (IARC) reporting over 19 million new cases in 2020 alone. Surgical procedures such as tumor resections and biopsies are critical components of cancer treatment, driving the demand for high-quality surgical blades. In addition, the rising prevalence of diabetes, which affects over 422 million people worldwide as per WHO estimates, often leads to complications like diabetic foot ulcers that require surgical management.  These chronic conditions highlight the critical need for surgical interventions, thereby escalating the demand for surgical blades.

The development of minimally invasive surgeries has revolutionized the medical field, requiring more precise and specialized surgical instruments, including blades. For instance, laparoscopic surgeries, which involve small incisions and the use of cameras and specialized tools, demand highly sharp and precise blades to ensure minimal tissue damage and quicker patient recovery. These technological advancements not only improve surgical outcomes but also increase the frequency of surgeries performed, thus boosting the demand for advanced surgical blades. With advancements in medical technology and improved healthcare infrastructure, the accessibility & safety of surgical interventions have significantly increased. This has led to a rise in elective surgeries, such as cosmetic and orthopedic procedures, and necessary surgeries, including cardiovascular & cancer-related operations. For instance, according to McLeod Health statistics, in 2022, a total of 18,577,953 orthopedic procedures were performed in the U.S.

The aging global population is also a crucial factor propelling the market growth. As life expectancy increases, the elderly population is growing, leading to a higher incidence of age-related health issues that often require surgical intervention. For instance, conditions such as osteoarthritis, cataracts, and various forms of cancer are more prevalent among older adults, necessitating surgical treatment. According to the CDC, adults aged 65 and above are at a higher risk of heart disease, COPD, diabetes, cancer, neurological problems, and other chronic illnesses. Patients with such illnesses require surgeries, which drives the demand for surgical blades.

Browse through Grand View Research's Medical Devices Industry Research Reports.

  • The global stainless steel market size was estimated at USD 117.63 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2030.
  • The global laryngoscopes blades and handles market size was estimated at USD 931.0 million in 2023 and is expected to grow at a CAGR of 9.12% from 2024 to 2030.

Surgical Blade Market Segmentation

Grand View Research has segmented the global surgical blade market based on product, material, end use, and regions:

Surgical Blade Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Stainless steel
  • High-grade carbon steel
  • Others

Surgical Blade Material Outlook (Revenue, USD Million, 2018 - 2030)

  • Sterile
  • Non-sterile

Surgical Blade End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Surgical Blade Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

  • US.
  • Canada
  • Mexico

Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway

Asia Pacific

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand

Latin America

  • Brazil
  • Argentina

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

  • Medtronic Plc
  • Johnson & Johnson Service, Inc.
  • Conmed Corporation
  • Integra LifeSciences
  • Smith & Nephew
  • Becton, Dickinson and Company (BD)
  • Braun Melsungen Ag
  • Cadence Inc
  • Integer Holdings Corporation
  • Olympus Corporation
  • Stryker
  • Boston Scientific Corporation
  • Erbe Elektromedizin Gmbh
  • 3M Healthcare

Recent Developments

  • In October 2020, Entrepix Medical, LLC, launched Planatome Technology, an advanced nano-polishing technique for surgical instruments. This technology creates a smooth, precise blade without manufacturer defects, reducing tissue trauma and ensuring a safer surgical experience compared to traditional scalpels
  • In June 2020, Olympus introduced two single-use electrosurgical knives for Endoscopic Submucosal Dissection (ESD) in the U.S. Both knives feature integrated submucosal injection for efficient, safe, and reliable ESD performance

Order a free sample PDF of the Surgical Blade Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.